Nicolan
Executive Summary
Elan files NDA for the transdermal nicotine patch product. When approved, Nicolan will be marketed in the U.S. by Warner-Lambert's Parke-Davis unit. Ireland-based controlled release R&D firm Elan will receive manufacturing and royalty fees.